{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:25:37Z","timestamp":1789748737156,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.neuroscience.2012.09.020","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T09:41:25Z","timestamp":1348047685000},"page":"411-420","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Glycogen synthase kinase 3-specific inhibitor AR-A014418 decreases neuropathic pain in mice: Evidence for the mechanisms of action"],"prefix":"10.1016","volume":"226","author":[{"given":"L.","family":"Mazzardo-Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.F.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Stramosk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"Cidral-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2012.09.020_b0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2010.08.020","article-title":"Spontaneous itch in the absence of hyperalgesia in a mouse hindpaw dry skin model","volume":"484","author":"Akiyama","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0010","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1021\/cr000110o","article-title":"Glycogen synthase kinase-3: properties, functions, and regulation","volume":"101","author":"Ali","year":"2001","journal-title":"Chem Rev"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0015","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpneuro0113","article-title":"Mechanisms of disease: neuropathic pain-a clinical perspective","volume":"2","author":"Baron","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev.pharmtox.011008.145634","article-title":"Akt\/GSK3 signaling in the action of psychotropic drugs","volume":"49","author":"Beaulieu","year":"2009","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennet","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2009.09.007","article-title":"Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)","volume":"31","author":"Beurel","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0040","doi-asserted-by":"crossref","first-page":"45937","DOI":"10.1074\/jbc.M306268200","article-title":"Structural insights and biological effects of glycogen synthasekinase 3-specific inhibitor AR-A014418","volume":"278","author":"Bhat","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuroscience.2011.07.075","article-title":"Neuroprotective and neuroregenerative effects of low-intensity aerobic exercise on sciatic nerve crush injury in mice","volume":"194","author":"Bobinski","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(02)02428-7","article-title":"Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice","volume":"453","author":"Bortalanza","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0060","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1073\/pnas.0901507106","article-title":"Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli","volume":"106","author":"Cavanaugh","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ejpain.2007.08.008","article-title":"Dopamine receptors in the anterior insular cortex modulate long term nociception in the rat","volume":"12","author":"Coffeen","year":"2008","journal-title":"Eur J Pain"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0075","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3\u03b2phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0080","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0085","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","article-title":"Glycogensynthasekinase-3 fromrabbitskeletalmuscle. Separationfromcyclic-AMP-dependent protein kinase and phosphorylase kinase","volume":"107","author":"Embi","year":"1980","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.ne.14.030191.001251","article-title":"Neurotransmitters in nociceptivemodulatory circuits","volume":"14","author":"Fields","year":"1991","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0095","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.febslet.2007.03.018","article-title":"GSK3 alpha and GSK3 beta are necessary for axon formation","volume":"581","author":"Garrido","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0100","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.npp.1300731","article-title":"Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs","volume":"30","author":"Gould","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of glycogen synthasekinase 3beta in cellular signaling","volume":"65","author":"Grimes","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0110","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.4049\/jimmunol.171.10.5034","article-title":"Reprogramming of IL-10 activity and signaling by IFN-gamma","volume":"171","author":"Herrero","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35017574","article-title":"Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation","volume":"406","author":"Hoeflich","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","article-title":"Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics","volume":"32","author":"Jope","year":"2007","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2007.03.003","article-title":"Antidepressant-like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of the noradrenergic system","volume":"565","author":"Kaster","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0135","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2174\/1389450110607011377","article-title":"Glycogen synthase kinase-3 \u2013 an overview of an over-achieving protein kinase","volume":"7","author":"Kockeritz","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0140","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0195-5616(08)70003-2","article-title":"Physiology of pain","volume":"30","author":"Lamont","year":"2000","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0145","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/jcb.21868","article-title":"IFN-gamma synergizes with LPS to induce nitric oxide biosynthesis through glycogen synthase kinase-3-inhibited IL-10","volume":"105","author":"Lin","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0150","first-page":"1426","article-title":"In vivo regulation of glycogen synthasekinase-3\u03b2 (gsk3\u03b2) by serotonergic activity in mouse brain","volume":"29","author":"Li","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pain.2007.06.018","article-title":"A systematic review of the effect of waiting for treatment for chronic pain","volume":"136","author":"Lynch","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3959(98)00045-1","article-title":"Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates","volume":"76","author":"Malmberg","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpain.2010.06.007","article-title":"The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice","volume":"12","author":"Martins","year":"2011","journal-title":"J Pain"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0175","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0022-3565(24)29479-9","article-title":"Antidepressant-like behavioral effects in 5-hydroxytryptamine1A and 5 hydroxytryptamine1B receptor mutant mice","volume":"298","author":"Mayorga","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0180","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1124\/jpet.105.092825","article-title":"Analysis of the antinociceptive effect of the flavonoidmyricitrin: evidence for a role of the l-arginine-nitric oxide and protein kinase C pathways","volume":"316","author":"Meotti","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0185","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2008.10.013","article-title":"Glycogen synthase kinase-3 and cancer: good cop, bad cop?","volume":"14","author":"Patel","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0190","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/026988119801200404","article-title":"Psychopharmacological role of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms","volume":"12","author":"Redrobe","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0195","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.pnpbp.2008.05.020","article-title":"Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice","volume":"32","author":"Rosa","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0200","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neuropharm.2005.01.012","article-title":"Mechanisms involved in the antinociception caused by agmatine in mice","volume":"48","author":"Santos","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.expneurol.2008.09.018","article-title":"D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism","volume":"215","author":"Sheng","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0215","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1001\/jama.290.18.2443","article-title":"Lost productive time and cost due to common pain conditions in the US workforce","volume":"290","author":"Stewart","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0220","doi-asserted-by":"crossref","first-page":"39541","DOI":"10.1074\/jbc.M403449200","article-title":"Genetic deletion of glycogen synthase kinase-3beta abrogates activation of Ikappa- \u03b2alphakinase, JNK, Akt, and p44\/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor","volume":"279","author":"Takada","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.brainresrev.2004.07.004","article-title":"Descending control of persistent pain: inhibitory or facilitatory?","volume":"46","author":"Vanegas","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0230","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cyto.2010.10.009","article-title":"Glycogen synthasekinase 3: a point of convergence for the host inflammatory response","volume":"53","author":"Wang","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0235","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood.V86.3.1184.1184","article-title":"Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages","volume":"86","author":"Weinberg","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00495547","article-title":"Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after a-methyl-p-tyrosine; time-and dose\u2013response relationships","volume":"304","author":"Widerlov","year":"1978","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0245","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain: aetiology, symptoms, mechanisms and management","volume":"353","author":"Woolf","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0250","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tibs.2009.10.002","article-title":"GSK3: a multifaceted kinase in Wnt signaling","volume":"35","author":"Wu","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0255","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neulet.2011.10.029","article-title":"Effects of clonidine on bilateral pain behaviors and inflammatory response in rats under the state of neuropathic pain","volume":"505","author":"Zhang","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0260","first-page":"4","article-title":"Neuronal and microglial mechanisms of neuropathic pain","volume":"30","author":"Zhuo","year":"2011","journal-title":"Mol Brain"},{"key":"10.1016\/j.neuroscience.2012.09.020_b0265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigation of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452212009232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452212009232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:10:39Z","timestamp":1744161039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452212009232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":51,"alternative-id":["S0306452212009232"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2012.09.020","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}